Global Genomic Biomarkers Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Genomic Biomarkers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Oncology
  • 1.2.3 Cardiovascular Diseases
  • 1.2.4 Neurological Diseases
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Genomic Biomarkers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Diagnostic and Research Laboratories
  • 1.3.3 Hospitals
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Genomic Biomarkers Market Perspective (2017-2028)
• 2.2 Genomic Biomarkers Growth Trends by Region
  • 2.2.1 Genomic Biomarkers Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Genomic Biomarkers Historic Market Size by Region (2017-2022)
  • 2.2.3 Genomic Biomarkers Forecasted Market Size by Region (2023-2028)
• 2.3 Genomic Biomarkers Market Dynamics
  • 2.3.1 Genomic Biomarkers Industry Trends
  • 2.3.2 Genomic Biomarkers Market Drivers
  • 2.3.3 Genomic Biomarkers Market Challenges
  • 2.3.4 Genomic Biomarkers Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Genomic Biomarkers Players by Revenue
  • 3.1.1 Global Top Genomic Biomarkers Players by Revenue (2017-2022)
  • 3.1.2 Global Genomic Biomarkers Revenue Market Share by Players (2017-2022)
• 3.2 Global Genomic Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Genomic Biomarkers Revenue
• 3.4 Global Genomic Biomarkers Market Concentration Ratio
  • 3.4.1 Global Genomic Biomarkers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Genomic Biomarkers Revenue in 2021
• 3.5 Genomic Biomarkers Key Players Head office and Area Served
• 3.6 Key Players Genomic Biomarkers Product Solution and Service
• 3.7 Date of Enter into Genomic Biomarkers Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Genomic Biomarkers Breakdown Data by Type

• 4.1 Global Genomic Biomarkers Historic Market Size by Type (2017-2022)
• 4.2 Global Genomic Biomarkers Forecasted Market Size by Type (2023-2028)

5 Genomic Biomarkers Breakdown Data by Application

• 5.1 Global Genomic Biomarkers Historic Market Size by Application (2017-2022)
• 5.2 Global Genomic Biomarkers Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Genomic Biomarkers Market Size (2017-2028)
• 6.2 North America Genomic Biomarkers Market Size by Type
  • 6.2.1 North America Genomic Biomarkers Market Size by Type (2017-2022)
  • 6.2.2 North America Genomic Biomarkers Market Size by Type (2023-2028)
  • 6.2.3 North America Genomic Biomarkers Market Share by Type (2017-2028)
• 6.3 North America Genomic Biomarkers Market Size by Application
  • 6.3.1 North America Genomic Biomarkers Market Size by Application (2017-2022)
  • 6.3.2 North America Genomic Biomarkers Market Size by Application (2023-2028)
  • 6.3.3 North America Genomic Biomarkers Market Share by Application (2017-2028)
• 6.4 North America Genomic Biomarkers Market Size by Country
  • 6.4.1 North America Genomic Biomarkers Market Size by Country (2017-2022)
  • 6.4.2 North America Genomic Biomarkers Market Size by Country (2023-2028)
  • 6.4.3 U.S.
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Genomic Biomarkers Market Size (2017-2028)
• 7.2 Europe Genomic Biomarkers Market Size by Type
  • 7.2.1 Europe Genomic Biomarkers Market Size by Type (2017-2022)
  • 7.2.2 Europe Genomic Biomarkers Market Size by Type (2023-2028)
  • 7.2.3 Europe Genomic Biomarkers Market Share by Type (2017-2028)
• 7.3 Europe Genomic Biomarkers Market Size by Application
  • 7.3.1 Europe Genomic Biomarkers Market Size by Application (2017-2022)
  • 7.3.2 Europe Genomic Biomarkers Market Size by Application (2023-2028)
  • 7.3.3 Europe Genomic Biomarkers Market Share by Application (2017-2028)
• 7.4 Europe Genomic Biomarkers Market Size by Country
  • 7.4.1 Europe Genomic Biomarkers Market Size by Country (2017-2022)
  • 7.4.2 Europe Genomic Biomarkers Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Genomic Biomarkers Market Size (2017-2028)
• 8.2 Asia-Pacific Genomic Biomarkers Market Size by Type
  • 8.2.1 Asia-Pacific Genomic Biomarkers Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Genomic Biomarkers Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Genomic Biomarkers Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Genomic Biomarkers Market Size by Application
  • 8.3.1 Asia-Pacific Genomic Biomarkers Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Genomic Biomarkers Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Genomic Biomarkers Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Genomic Biomarkers Market Size by Region
  • 8.4.1 Asia-Pacific Genomic Biomarkers Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Genomic Biomarkers Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Genomic Biomarkers Market Size (2017-2028)
• 9.2 Latin America Genomic Biomarkers Market Size by Type
  • 9.2.1 Latin America Genomic Biomarkers Market Size by Type (2017-2022)
  • 9.2.2 Latin America Genomic Biomarkers Market Size by Type (2023-2028)
  • 9.2.3 Latin America Genomic Biomarkers Market Share by Type (2017-2028)
• 9.3 Latin America Genomic Biomarkers Market Size by Application
  • 9.3.1 Latin America Genomic Biomarkers Market Size by Application (2017-2022)
  • 9.3.2 Latin America Genomic Biomarkers Market Size by Application (2023-2028)
  • 9.3.3 Latin America Genomic Biomarkers Market Share by Application (2017-2028)
• 9.4 Latin America Genomic Biomarkers Market Size by Country
  • 9.4.1 Latin America Genomic Biomarkers Market Size by Country (2017-2022)
  • 9.4.2 Latin America Genomic Biomarkers Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Genomic Biomarkers Market Size (2017-2028)
• 10.2 Middle East & Africa Genomic Biomarkers Market Size by Type
  • 10.2.1 Middle East & Africa Genomic Biomarkers Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Genomic Biomarkers Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Genomic Biomarkers Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Genomic Biomarkers Market Size by Application
  • 10.3.1 Middle East & Africa Genomic Biomarkers Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Genomic Biomarkers Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Genomic Biomarkers Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Genomic Biomarkers Market Size by Country
  • 10.4.1 Middle East & Africa Genomic Biomarkers Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Genomic Biomarkers Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Thermo Fisher Scientific
  • 11.1.1 Thermo Fisher Scientific Company Details
  • 11.1.2 Thermo Fisher Scientific Business Overview
  • 11.1.3 Thermo Fisher Scientific Genomic Biomarkers Introduction
  • 11.1.4 Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2017-2022)
  • 11.1.5 Thermo Fisher Scientific Recent Developments
• 11.2 Roche
  • 11.2.1 Roche Company Details
  • 11.2.2 Roche Business Overview
  • 11.2.3 Roche Genomic Biomarkers Introduction
  • 11.2.4 Roche Revenue in Genomic Biomarkers Business (2017-2022)
  • 11.2.5 Roche Recent Developments
• 11.3 Aepodia
  • 11.3.1 Aepodia Company Details
  • 11.3.2 Aepodia Business Overview
  • 11.3.3 Aepodia Genomic Biomarkers Introduction
  • 11.3.4 Aepodia Revenue in Genomic Biomarkers Business (2017-2022)
  • 11.3.5 Aepodia Recent Developments
• 11.4 Myriad Genetics
  • 11.4.1 Myriad Genetics Company Details
  • 11.4.2 Myriad Genetics Business Overview
  • 11.4.3 Myriad Genetics Genomic Biomarkers Introduction
  • 11.4.4 Myriad Genetics Revenue in Genomic Biomarkers Business (2017-2022)
  • 11.4.5 Myriad Genetics Recent Developments
• 11.5 Eurofins Scientific
  • 11.5.1 Eurofins Scientific Company Details
  • 11.5.2 Eurofins Scientific Business Overview
  • 11.5.3 Eurofins Scientific Genomic Biomarkers Introduction
  • 11.5.4 Eurofins Scientific Revenue in Genomic Biomarkers Business (2017-2022)
  • 11.5.5 Eurofins Scientific Recent Developments
• 11.6 QIAGEN
  • 11.6.1 QIAGEN Company Details
  • 11.6.2 QIAGEN Business Overview
  • 11.6.3 QIAGEN Genomic Biomarkers Introduction
  • 11.6.4 QIAGEN Revenue in Genomic Biomarkers Business (2017-2022)
  • 11.6.5 QIAGEN Recent Developments
• 11.7 Bio-Rad Laboratories
  • 11.7.1 Bio-Rad Laboratories Company Details
  • 11.7.2 Bio-Rad Laboratories Business Overview
  • 11.7.3 Bio-Rad Laboratories Genomic Biomarkers Introduction
  • 11.7.4 Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2017-2022)
  • 11.7.5 Bio-Rad Laboratories Recent Developments
• 11.8 Genomic Health
  • 11.8.1 Genomic Health Company Details
  • 11.8.2 Genomic Health Business Overview
  • 11.8.3 Genomic Health Genomic Biomarkers Introduction
  • 11.8.4 Genomic Health Revenue in Genomic Biomarkers Business (2017-2022)
  • 11.8.5 Genomic Health Recent Developments
• 11.9 Liquid Genomics
  • 11.9.1 Liquid Genomics Company Details
  • 11.9.2 Liquid Genomics Business Overview
  • 11.9.3 Liquid Genomics Genomic Biomarkers Introduction
  • 11.9.4 Liquid Genomics Revenue in Genomic Biomarkers Business (2017-2022)
  • 11.9.5 Liquid Genomics Recent Developments
• 11.10 Epigenomics
  • 11.10.1 Epigenomics Company Details
  • 11.10.2 Epigenomics Business Overview
  • 11.10.3 Epigenomics Genomic Biomarkers Introduction
  • 11.10.4 Epigenomics Revenue in Genomic Biomarkers Business (2017-2022)
  • 11.10.5 Epigenomics Recent Developments
• 11.11 AROS Applied Biotechnology
  • 11.11.1 AROS Applied Biotechnology Company Details
  • 11.11.2 AROS Applied Biotechnology Business Overview
  • 11.11.3 AROS Applied Biotechnology Genomic Biomarkers Introduction
  • 11.11.4 AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2017-2022)
  • 11.11.5 AROS Applied Biotechnology Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Genomic Biomarkers Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Oncology
• Table 3. Key Players of Cardiovascular Diseases
• Table 4. Key Players of Neurological Diseases
• Table 5. Key Players of Others
• Table 6. Global Genomic Biomarkers Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 7. Global Genomic Biomarkers Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 8. Global Genomic Biomarkers Market Size by Region (2017-2022) & (US$ Million)
• Table 9. Global Genomic Biomarkers Market Share by Region (2017-2022)
• Table 10. Global Genomic Biomarkers Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 11. Global Genomic Biomarkers Market Share by Region (2023-2028)
• Table 12. Genomic Biomarkers Market Trends
• Table 13. Genomic Biomarkers Market Drivers
• Table 14. Genomic Biomarkers Market Challenges
• Table 15. Genomic Biomarkers Market Restraints
• Table 16. Global Genomic Biomarkers Revenue by Players (2017-2022) & (US$ Million)
• Table 17. Global Genomic Biomarkers Revenue Share by Players (2017-2022)
• Table 18. Global Top Genomic Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Biomarkers as of 2021)
• Table 19. Ranking of Global Top Genomic Biomarkers Companies by Revenue (US$ Million) in 2021
• Table 20. Global 5 Largest Players Market Share by Genomic Biomarkers Revenue (CR5 and HHI) & (2017-2022)
• Table 21. Key Players Headquarters and Area Served
• Table 22. Key Players Genomic Biomarkers Product Solution and Service
• Table 23. Date of Enter into Genomic Biomarkers Market
• Table 24. Mergers & Acquisitions, Expansion Plans
• Table 25. Global Genomic Biomarkers Market Size by Type (2017-2022) & (US$ Million)
• Table 26. Global Genomic Biomarkers Revenue Market Share by Type (2017-2022)
• Table 27. Global Genomic Biomarkers Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 28. Global Genomic Biomarkers Revenue Market Share by Type (2023-2028)
• Table 29. Global Genomic Biomarkers Market Size by Application (2017-2022) & (US$ Million)
• Table 30. Global Genomic Biomarkers Revenue Share by Application (2017-2022)
• Table 31. Global Genomic Biomarkers Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 32. Global Genomic Biomarkers Revenue Share by Application (2023-2028)
• Table 33. North America Genomic Biomarkers Market Size by Type (2017-2022) & (US$ Million)
• Table 34. North America Genomic Biomarkers Market Size by Type (2023-2028) & (US$ Million)
• Table 35. North America Genomic Biomarkers Market Size by Application (2017-2022) & (US$ Million)
• Table 36. North America Genomic Biomarkers Market Size by Application (2023-2028) & (US$ Million)
• Table 37. North America Genomic Biomarkers Market Size by Country (2017-2022) & (US$ Million)
• Table 38. North America Genomic Biomarkers Market Size by Country (2023-2028) & (US$ Million)
• Table 39. Europe Genomic Biomarkers Market Size by Type (2017-2022) & (US$ Million)
• Table 40. Europe Genomic Biomarkers Market Size by Type (2023-2028) & (US$ Million)
• Table 41. Europe Genomic Biomarkers Market Size by Application (2017-2022) & (US$ Million)
• Table 42. Europe Genomic Biomarkers Market Size by Application (2023-2028) & (US$ Million)
• Table 43. Europe Genomic Biomarkers Market Size by Country (2017-2022) & (US$ Million)
• Table 44. Europe Genomic Biomarkers Market Size by Country (2023-2028) & (US$ Million)
• Table 45. Asia Pacific Genomic Biomarkers Market Size by Type (2017-2022) & (US$ Million)
• Table 46. Asia Pacific Genomic Biomarkers Market Size by Type (2023-2028) & (US$ Million)
• Table 47. Asia Pacific Genomic Biomarkers Market Size by Application (2017-2022) & (US$ Million)
• Table 48. Asia Pacific Genomic Biomarkers Market Size by Application (2023-2028) & (US$ Million)
• Table 49. Asia Pacific Genomic Biomarkers Market Size by Region (2017-2022) & (US$ Million)
• Table 50. Asia Pacific Genomic Biomarkers Market Size by Region (2023-2028) & (US$ Million)
• Table 51. Latin America Genomic Biomarkers Market Size by Type (2017-2022) & (US$ Million)
• Table 52. Latin America Genomic Biomarkers Market Size by Type (2023-2028) & (US$ Million)
• Table 53. Latin America Genomic Biomarkers Market Size by Application (2017-2022) & (US$ Million)
• Table 54. Latin America Genomic Biomarkers Market Size by Application (2023-2028) & (US$ Million)
• Table 55. Latin America Genomic Biomarkers Market Size by Country (2017-2022) & (US$ Million)
• Table 56. Latin America Genomic Biomarkers Market Size by Country (2023-2028) & (US$ Million)
• Table 57. Middle East and Africa Genomic Biomarkers Market Size by Type (2017-2022) & (US$ Million)
• Table 58. Middle East and Africa Genomic Biomarkers Market Size by Type (2023-2028) & (US$ Million)
• Table 59. Middle East and Africa Genomic Biomarkers Market Size by Application (2017-2022) & (US$ Million)
• Table 60. Middle East and Africa Genomic Biomarkers Market Size by Application (2023-2028) & (US$ Million)
• Table 61. Middle East and Africa Genomic Biomarkers Market Size by Country (2017-2022) & (US$ Million)
• Table 62. Middle East and Africa Genomic Biomarkers Market Size by Country (2023-2028) & (US$ Million)
• Table 63. Thermo Fisher Scientific Company Details
• Table 64. Thermo Fisher Scientific Business Overview
• Table 65. Thermo Fisher Scientific Genomic Biomarkers Product
• Table 66. Thermo Fisher Scientific Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
• Table 67. Thermo Fisher Scientific Recent Developments
• Table 68. Roche Company Details
• Table 69. Roche Business Overview
• Table 70. Roche Genomic Biomarkers Product
• Table 71. Roche Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
• Table 72. Roche Recent Developments
• Table 73. Aepodia Company Details
• Table 74. Aepodia Business Overview
• Table 75. Aepodia Genomic Biomarkers Product
• Table 76. Aepodia Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
• Table 77. Aepodia Recent Developments
• Table 78. Myriad Genetics Company Details
• Table 79. Myriad Genetics Business Overview
• Table 80. Myriad Genetics Genomic Biomarkers Product
• Table 81. Myriad Genetics Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
• Table 82. Myriad Genetics Recent Developments
• Table 83. Eurofins Scientific Company Details
• Table 84. Eurofins Scientific Business Overview
• Table 85. Eurofins Scientific Genomic Biomarkers Product
• Table 86. Eurofins Scientific Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
• Table 87. Eurofins Scientific Recent Developments
• Table 88. QIAGEN Company Details
• Table 89. QIAGEN Business Overview
• Table 90. QIAGEN Genomic Biomarkers Product
• Table 91. QIAGEN Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
• Table 92. QIAGEN Recent Developments
• Table 93. Bio-Rad Laboratories Company Details
• Table 94. Bio-Rad Laboratories Business Overview
• Table 95. Bio-Rad Laboratories Genomic Biomarkers Product
• Table 96. Bio-Rad Laboratories Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
• Table 97. Bio-Rad Laboratories Recent Developments
• Table 98. Genomic Health Company Details
• Table 99. Genomic Health Business Overview
• Table 100. Genomic Health Genomic Biomarkers Product
• Table 101. Genomic Health Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
• Table 102. Genomic Health Recent Developments
• Table 103. Liquid Genomics Company Details
• Table 104. Liquid Genomics Business Overview
• Table 105. Liquid Genomics Genomic Biomarkers Product
• Table 106. Liquid Genomics Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
• Table 107. Liquid Genomics Recent Developments
• Table 108. Epigenomics Company Details
• Table 109. Epigenomics Business Overview
• Table 110. Epigenomics Genomic Biomarkers Product
• Table 111. Epigenomics Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
• Table 112. Epigenomics Recent Developments
• Table 113. AROS Applied Biotechnology Company Details
• Table 114. AROS Applied Biotechnology Business Overview
• Table 115. AROS Applied Biotechnology Genomic Biomarkers Product
• Table 116. AROS Applied Biotechnology Revenue in Genomic Biomarkers Business (2017-2022) & (US$ Million)
• Table 117. AROS Applied Biotechnology Recent Developments
• Table 118. Research Programs/Design for This Report
• Table 119. Key Data Information from Secondary Sources
• Table 120. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Genomic Biomarkers Market Share by Type: 2021 VS 2028
• Figure 2. Oncology Features
• Figure 3. Cardiovascular Diseases Features
• Figure 4. Neurological Diseases Features
• Figure 5. Others Features
• Figure 6. Global Genomic Biomarkers Market Share by Application: 2021 VS 2028
• Figure 7. Diagnostic and Research Laboratories Case Studies
• Figure 8. Hospitals Case Studies
• Figure 9. Others Case Studies
• Figure 10. Genomic Biomarkers Report Years Considered
• Figure 11. Global Genomic Biomarkers Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 12. Global Genomic Biomarkers Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 13. Global Genomic Biomarkers Market Share by Region: 2021 VS 2028
• Figure 14. Global Genomic Biomarkers Market Share by Players in 2021
• Figure 15. Global Top Genomic Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Biomarkers as of 2021)
• Figure 16. The Top 10 and 5 Players Market Share by Genomic Biomarkers Revenue in 2021
• Figure 17. North America Genomic Biomarkers Market Size YoY (2017-2028) & (US$ Million)
• Figure 18. North America Genomic Biomarkers Market Size Market Share by Type (2017-2028)
• Figure 19. North America Genomic Biomarkers Market Size Market Share by Application (2017-2028)
• Figure 20. North America Genomic Biomarkers Market Size Share by Country (2017-2028)
• Figure 21. United States Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 22. Canada Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 23. Europe Genomic Biomarkers Market Size YoY (2017-2028) & (US$ Million)
• Figure 24. Europe Genomic Biomarkers Market Size Market Share by Type (2017-2028)
• Figure 25. Europe Genomic Biomarkers Market Size Market Share by Application (2017-2028)
• Figure 26. Europe Genomic Biomarkers Market Size Share by Country (2017-2028)
• Figure 27. Germany Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 28. France Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 29. U.K. Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. Italy Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. Russia Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 32. Nordic Countries Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 33. Asia-Pacific Genomic Biomarkers Market Size YoY (2017-2028) & (US$ Million)
• Figure 34. Asia Pacific Genomic Biomarkers Market Size Market Share by Type (2017-2028)
• Figure 35. Asia Pacific Genomic Biomarkers Market Size Market Share by Application (2017-2028)
• Figure 36. Asia Pacific Genomic Biomarkers Market Size Share by Region (2017-2028)
• Figure 37. China Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 38. Japan Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 39. South Korea Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. Southeast Asia Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 41. India Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 42. Australia Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 43. Latin America Genomic Biomarkers Market Size YoY (2017-2028) & (US$ Million)
• Figure 44. Latin America Genomic Biomarkers Market Size Market Share by Type (2017-2028)
• Figure 45. Latin America Genomic Biomarkers Market Size Market Share by Application (2017-2028)
• Figure 46. Latin America Genomic Biomarkers Market Size Share by Country (2017-2028)
• Figure 47. Mexico Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 48. Brazil Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 49. Middle East & Africa Genomic Biomarkers Market Size YoY (2017-2028) & (US$ Million)
• Figure 50. Middle East and Africa Genomic Biomarkers Market Size Market Share by Type (2017-2028)
• Figure 51. Middle East and Africa Genomic Biomarkers Market Size Market Share by Application (2017-2028)
• Figure 52. Middle East and Africa Genomic Biomarkers Market Size Share by Country (2017-2028)
• Figure 53. Turkey Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 54. Saudi Arabia Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 55. UAE Genomic Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
• Figure 57. Roche Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
• Figure 58. Aepodia Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
• Figure 59. Myriad Genetics Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
• Figure 60. Eurofins Scientific Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
• Figure 61. QIAGEN Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
• Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
• Figure 63. Genomic Health Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
• Figure 64. Liquid Genomics Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
• Figure 65. Epigenomics Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
• Figure 66. AROS Applied Biotechnology Revenue Growth Rate in Genomic Biomarkers Business (2017-2022)
• Figure 67. Bottom-up and Top-down Approaches for This Report
• Figure 68. Data Triangulation
• Figure 69. Key Executives Interviewed